Toll-like receptor 4 (TLR4) antibody, protein kinase B (AKT) inhibitor, LY 294002, and glycogen synthase kinase 3β (GSK-3β) inhibitor, LiCl, were used by Yu He and colleagues from Nantong University, ...
Inflammatory biomarkers in ischemic stroke: mechanisms, clinical applications, and future directions
Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by ...
Toll-like receptor (TLR) and saponin adjuvants have each improved vaccine potency and safety. Now, researchers at Stanford University report that combining them in a nanoparticle format improves not ...
Although the research featured in high-impact papers often resonates for years after the papers appear, these papers have actually remained at the center of debate, according to the authors and others ...
Co announces the presentation of preclinical data using antagonists of Toll-like receptor 7 and 9 in mouse models of lupus disease. "The antagonist candidates studied in mouse lupus models have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback